NASDAQ
DRTS
Last Price
US $12.34
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Alpha Tau Medical Ltd cash flow to debt ratio of -194.38% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Alpha Tau Medical Ltd's free cash flow has decreased 48.75% from $-22.02M last year to $-32.76M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Alpha Tau Medical Ltd's debt to equity ratio is 0.21, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Alpha Tau Medical Ltd's debt has increased relative to shareholder equity from 0.20 last year to 0.21 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Alpha Tau Medical Ltd has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Alpha Tau Medical Ltd earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Alpha Tau Medical Ltd has insufficient data to evaluate this check.
Financial stability - Short term assets vs short term liabilities.
Alpha Tau Medical Ltd's short-term assets of $78.30M exceed its short-term liabilities of $10.51M
Decreasing performance - ROA.
Alpha Tau Medical Ltd's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Alpha Tau Medical Ltd's return on equity of -73.23%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Alpha Tau Medical Ltd's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Alpha Tau Medical Ltd had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Alpha Tau Medical Ltd has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Alpha Tau Medical Ltd has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Alpha Tau Medical Ltd's yearly earnings has decreased 34.26% since last year from $-31.75M to $-42.63M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Alpha Tau Medical Ltd's yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance
Decreasing performance - ROIC.
ROIC -46.51% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Alpha Tau Medical Ltd has insufficient revenue history to calculate 3-year revenue CAGR.
Increasing performance - Revenue consistency.
Alpha Tau Medical Ltd had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Alpha Tau Medical Ltd had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Alpha Tau Medical Ltd has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Alpha Tau Medical Ltd has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Alpha Tau Medical Ltd is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Alpha Tau Medical Ltd has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Alpha Tau Medical Ltd has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Alpha Tau Medical Ltd has a price-to-book ratio of 15.96x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
Alpha Tau Medical Ltd has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-73.23%
Return on equity
ROIC: -46.51%
Valuation History
-19.0X
Price to Earnings
EV/EBITDA: -25.7X
Cash flow
Profit margin
-25.92%
(FY vs FY)
Cash flow Y/Y
-19.58%
(FY vs FY)
Fair Value
Market $12.34
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.